Journal: Open Forum Infectious Diseases
Article Title: Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic
doi: 10.1093/ofid/ofx023
Figure Lengend Snippet: Marker of infection in a donor not meeting the pre-established definition of pandemic influenza infection (pH1N1). (A) Time course of enzyme-linked immunospot response to peptide nucleoprotein (NP) 418-426 with the pandemic sequence, versus human immunodeficiency virus gag control peptide. (B) Summary of changes in other immune parameters between baseline (time point A) and follow up (time point B). ELISA, enzyme-linked immunosorbent assay; HI, hemagglutination inhibition; HIV, human immunodeficiency virus; IC95, 95% inhibitory titer; NI, neuraminidase inhibition; RBC, red blood cells; SFC, spot-forming cells; SF09, swine flu 2009 (pH1N1).
Article Snippet: Human immunodeficiency virus-Gag SLYNTVATL was obtained from New England Peptide (Gardner, MA).
Techniques: Marker, Infection, Enzyme-linked Immunospot, Sequencing, Virus, Control, Enzyme-linked Immunosorbent Assay, HI Assay, Inhibition